Dr Andrew Jones 

2005

• Jones AM, Dodd M, Govan J, Doherty C, Smith C, Isalska B, Webb Ak. (2005). Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center. Am J Respir Crit Care Med, 171( 3), 257-60. eScholarID:1d11237 | DOI:10.1164/rccm.200404-513OC
• Lewis D, Jones AM, Parkhill J, Speert D, Govan J, Lipuma J, Lory S, Webb Ak, Mahenthiralingam E. (2005). Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain. Am J Respir Cell Mol Biol, 33( 1), 56-64. eScholarID:1d28894

2004

• Jones AM, Dodd M, Govan J, Barcus V, Doherty C, Morris J, Webb Ak. (2004). Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax, 59( 11), 948-51. eScholarID:1d11239 | DOI:10.1136/thx.2003.017210

2003

• Jones AM, Govan J, Doherty C, Dodd M, Isalska B, Stanbridge T, Webb Ak. (2003). Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax, 58( 6), 525-7. eScholarID:1d7030 | DOI:10.1136/thorax.58.6.525

2002

• Jones AM, Dodd M, Doherty C, Govan J, Webb Ak. (2002). Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa. Thorax, 57( 11), 924-5. eScholarID:1d28560

2001

• Jones AM, Govan J, Doherty C, Dodd M, Isalska B, Stanbridge T, Webb Ak. (2001). Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet, 358( 9281), 557-8. eScholarID:1d7034